Mark Boshar was Appointed as Chief Operating Officer at Catamaran-Bio

Date of management change: February 15, 2020 

What Happened?

Cambridge, MA-based Catamaran-Bio Appointed Mark Boshar as Chief Operating Officer

 

About the Company

Catamaran Bio is developing novel, off-the-shelf CAR-NK cell therapies designed to treat a broad range of cancers, including solid tumors. Our proprietary capabilities enable us to harness the natural cancer-fighting properties of NK cells and enhance and tailor their effectiveness with the power of synthetic biology and innovative non-viral cell engineering. We are using our TAILWINDTM Platform, an integrated suite of technologies, to specifically address the end-to-end methods of engineering, processing and manufacturing NK cells and rapidly advance our pipeline of CAR-NK cell therapy programs. Our team combines experienced biopharmaceutical leadership with founding scientists who are pioneers in NK cell biology, engineering, manufacturing and clinical application. Catamaran is backed by leading financial and corporate investors, including SV Health Investors, Sofinnova Partners, Lightstone Ventures, Takeda Ventures and Astellas Venture Management.

 

About the Person

Mark Boshar is Chief Operating Officer at Catamaran Bio. Previously, Mark held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Osborne Shelley, Ryback Daniel, Robinson Deirdre, Adefioye Elizabeth, Pearson Lauren, Carrasqueira Mariana, Bailey Erin, Cachinero-Sanchez Benito, Fitzmorris Patrick, Styler Ellen, Kristoff John

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.